Home › Research › Tau biomarkers
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YA, van Elk EJ, Scheltens P, van der Flier WM.. Neurology, 2009-10-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective CSF biomarkers amyloid beta 1-42 (Abeta(42)), total tau (tau), and tau phosphorylated at threonine 181 (p-tau-181) are useful diagnostic markers for Alzheimer disease (AD). Less is known about these biomarkers as predictors for further cognitive decline in patients with AD. We hypothesized that high tau, especially in combination with relatively low p-tau-181, is a marker of rapid decline, since it has been associated with fast neuronal degeneration.
What this study adds
Evidence grade: Low
The record lists 151 participants. This study tested whether cerebrospinal fluid biomarkers amyloid beta 1-42, total tau, and tau phosphorylated at threonine 181 predict the rate of further cognitive decline in patients who already have Alzheimer disease. It is a prediction study and does not test any treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kester, M. I., van der Vlies, A. E., Blankenstein, M. A., Pijnenburg, Y. A., van Elk, E. J., Scheltens, P., et al. (2009). CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology. https://doi.org/10.1212/wnl.0b013e3181bd8271
Vancouver
Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YA, van Elk EJ, Scheltens P, et al. CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology. 2009. doi:10.1212/wnl.0b013e3181bd8271. PMID: 19858456.
BibTeX
@article{kester2009-19858456,
author = {Kester, M. I. and van der Vlies, A. E. and Blankenstein, M. A. and Pijnenburg, Y. A. and van Elk, E. J. and Scheltens, P. and van der Flier, W. M.},
title = {{CSF biomarkers predict rate of cognitive decline in Alzheimer disease}},
journal = {Neurology},
year = {2009},
doi = {10.1212/wnl.0b013e3181bd8271},
pmid = {19858456},
url = {https://doi.org/10.1212/wnl.0b013e3181bd8271}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Less is known about these biomarkers as predictors for further cognitive decline in patients with AD.
- We hypothesized that high tau, especially in combination with relatively low p-tau-181, is a marker of rapid decline, since it has been associated with fast neuronal degeneration.
- Methods A total of 151 patients with AD of whom we had baseline CSF were included from our memory clinic.
- All patients had at least 2 Mini-Mental State Examination (MMSE) scores, obtained no less than 1 year apart.
Why it matters
This study tested whether cerebrospinal fluid biomarkers amyloid beta 1-42, total tau, and tau phosphorylated at threonine 181 predict the rate of further cognitive decline in patients who already have Alzheimer disease. It is a prediction study and does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants151
- Evidence strengthLow
How this study scored 52/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 151 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 159 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.4 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 3 / 6 | Cited 6.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 14 other studies in this library |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Wiesje M. van der Flier: h-index 132 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Amsterdam UMC Location Vrije Universiteit Amsterdam: institution h-index 938 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19858456) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Later studies that cite this one
14 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.